Back to search

Article

Prognostic significance of Claudin18.2 expression in patients with gastric cancer: Insights from original research and meta-analysis

2025-04-02

Abstract excerpt

<title>Abstract</title> <p> <bold>Background:</bold> Claudin 18.2 (CLDN18.2) is a novel treatment target for patients with unresectable or stage IV gastric cancer. However, it remains unclear whether the expression of CLDN18.2 affects survival outcomes. <bold>Methods:</bold> In total, 586 patients with GC were enrolled in this study. CLDN18.2 expression in cancer cells was analyzed by immunohistochemistry. Co...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
46deb181-96fe-5075-b4aa-2772deb87c91
DOI
10.21203/rs.3.rs-6145125/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Prognostic significance of Claudin18.2 expression in patients with gastric cancer: Insights from original research and meta-analysisDOI 10.21203/rs.3.rs-6145125/v1
The role of claudin 18.2 and HER-2 in pancreatic cancer outcomesSemantic proximity
Immunohistochemical analysis of colorectal cancer with gastric phenotype: claudin-18 is associated with poor prognosis.Semantic proximity
Immunohistochemical expression of Claudin18.2 in borderline and malignant gynecologic tumors: Results from a pilot studySemantic proximity
Claudin 18.2 is a potential therapeutic target for zolbetuximab in pancreatic ductal adenocarcinomaSemantic proximity
Claudin-1, A Double-Edged Sword in CancerSemantic proximity
Spatial expression of claudin 18.2 in matched primaries and metastases of tubo-ovarian carcinoma of all subtypesSemantic proximity
Claudin-18.2 expression is frequent in remnant gastric carcinoma and associated with microsatellite instability and Epstein-Barr viral infection phenotypes.Semantic proximity
Treatment Selection for Patients with HER2-Negative Metastatic Gastric Cancer Expressing Claudin 18.2 and PD-L1Semantic proximity
Car-γδ T Cells Targeting Claudin18.2 Show Superior Cytotoxicity Against Solid Tumor Compared to Traditional Car-αβ T CellsSemantic proximity
Down-regulation of the claudin-18 gene, identified through serial analysis of gene expression data analysis, in gastric cancer with an intestinal phenotype.Semantic proximity
Claudin-18 Splice Variant 2 Is a Pan-Cancer Target Suitable for Therapeutic Antibody DevelopmentSemantic proximity
Identification of Claudin-6 as a Molecular Biomarker in Pan-Cancer Through Multiple Omics Integrative AnalysisSemantic proximity
Select a neighboring publication to make it the new centre.